CopyrightX: Article 13

Panel Two: Online
Service Providers, Automated Anti-piracy Systems, and Article 13 [like CDA 230,
it may never lose the initial number even if it no longer fits the statutory
numbering]
Moderator: Jennifer
Esch
Giancarlo Frosio:
Copyright and Article 13
Summary of current
provisions.  Automated technology is the intended
effect. Hard to see how that can be done without general monitoring of all
contents of a platform for unlimited times. 
Scarlett court made clear that
fundamental rights are implicated—freedom of information and expression—and automated
technologies are not proportional, especially given that they might jeopardize a
business.  Limitations and exceptions
also need to be accommodated somehow.
Ginka Hristova: The
Effects of EU Article 11 and Article 13
Content ID is the
prime example that people give of how it should be done but Content ID works
badly—it’s not a good model.  [And the
same content owners complain bitterly about Content ID not being good
enough!]  Burden of proof is reversed
from the Electronic Commerce Directive. 
Now platforms will have to prove that they’re making enough efforts to
avoid direct liability.  Collisions
w/GDRP as well.  Especially when determining
whether exceptions and limitations apply, much information will need to be
collected.
Mohammed Iriqat:
Copyright Piracy in the Arab World
Extensive unlicensed
downloading of music, movies, software. 60% of software running in the Arab
world is unlicensed.  Millions of DVDs.  Gov’t institutions and universities participate.  Microsoft Office $5 an unlicensed CD,
compared to $70 authorized price.  $2
billion in calculated economic loss. 
Possible solutions: collective management organizations, but there are
just 5 Arab CMOs and 22 Arab countries. Raise awareness. 95% of Arab citizens
don’t see a problem with illegal downloads. 
Internet laws like DMCA, which are lacking in the Arab world.  Customs authorities: no control over entry of
pirate CDs.  World Cup 2018: Four
countries blockaded Qatar, which had the rights to broadcast; they made sites
to distribute the World Cup w/o authority of the Qatari rightsowner. Intergovernmental
conflict.  Qatar went to WIPO for
arbitration, but WIPO hasn’t made a final decision.
Jordan Gimbel:
Twitch and the Likely Effects of Article 13
Wide spectrum of
online service providers and treatments of unauthorized use/debates w/ different
rightsholders: music, film, gaming.  Twitch
isn’t YouTube or Twitter; has some features but also Patreon-like.  You can live broadcast your gaming.
Streaming could
infringe, but game publishers/developers often license streaming—an attractive
complement to their titles.  Many license
monetization by individual streamers. But we’re not immune from unauthorized
works appearing.  We do see notices for
(1) livestreaming sports; (2) violations of embargo conditions on new games;
(3) user disputes over emotes (users who create designs for the overlay).  Twitch as complement: NBA brought its
G-League (farm team) cames to Twitch, allowing others to costream it (add it to
their own channel with their own overlays). 
NFL selected a few costreamers who could stream it to their own audience
w/their own commentary.
We process DMCA
notices in minutes; suspend live broadcast for 24 hours. For VOD works we mute
the songs—if you create an archive of a live broadcast, we scan & create
audio fingerprints w/Audible Magic and mute portions for matches.  Some rightsholders have priority access—soccer
leagues, game companies—to act w/o needing to send notice.
How does this change
under Art. 17/13?  Obligation to license,
notice and staydown: filters are the only option.  Reference files aren’t available for
livestreams so that’s a challenge. This content is yet to be created.  And the overlays are different digital
assets. We can scan the audio, but scanning images on overlays from multiple
sources are a challenge. Scratching our heads. 
Algorithmic tools are going to be needed; taking $ from other
developments. Open Qs.  Mistakes in
livestreams lead to suspension of channel, which impacts people’s
livelihoods.  Filter’s false positives
are therefore concerning. Crossborder implementation challenges: different
rightsholders across Europe.  GEMA
(German PRO) announced that it thought it should be given a larger negotiating
power on behalf of images as well as music. That’s great, but only for Germany.
Q: what could gov’ts
do/what are the missed opportunities?
Hristova:
implementation legislation.
Q re real people
depicted in games.
Gimbel: US-centric
answer: right of publicity is what’s debated.
Q: where do you get
the filters from? Google?
Gimble: question of
market power.  Content ID has been around
for a while and they’re set on approach. Compliance w/best efforts: we’re
trying to figure out whether that means we can engage in licensing from a
vendor, but may have to develop a filter that maps to your service using your
reference materials. Open Q: does the law require us to build our own tech to
do that because we have a different way in which we serve content, w/overlays
that are different from other services. [One of my biggest questions about all
this is how licensing is going to work for visual works—is there just going to
be a wealth transfer from platforms to the small percentage of visual artists who
are represented by PROs and to the PROs themselves based on the overall “value”
of visual works?  Whereas music really
does have a high percentage of covered material deliberately part of a PRO,
visual works don’t and won’t.]
Terry Fisher: some
suggestions about implementation: make platforms responsible for costs of
wrongful blocking of noninfringing materials in order to incentivize balancing
and use of mechanisms such as arbitration or option system to reduce social
costs of this regime.

from Blogger http://bit.ly/2Q2FH4I

Posted in Uncategorized | Tagged , , | Leave a comment

CopyrightX: UGC panel

Panel One:
User-generated Content, Digital Labor, and Collaborative Authorship
Moderator: Bethany
Rabe
Rebecca Tushnet: Fanworks,
Fair Use, and Self-Actualization Through Transformative Expression
Title assigned a few
months ago is a little misleading because I actually wanted to take the
opportunity to talk about the Copyright Office’s recent
report on moral rights, though I’m happy to talk about anything
fanwork related during the panel discussion and Q&A.  I was one of the founders of the nonprofit
Organization for Transformative Works.  OTW runs the Archive of Our Own, which hosts
noncommercial transformative works by fans of existing works, of people, or
really of anything about which one might create new art. From our recent
fact sheet I can
tell you that we have over 1.2 million registered users and 4.7 million
fanworks, as well as tens of millions of visits per week. “Our open-source code
was built from the ground up by fans for fans…. Our users are fans of every
sort—teenagers and grandparents, first-time writers and professional
authors—from all around the world, creating fanworks” for nearly 32,000
different fandoms.  From the beginning,
it was a priority to be ad-free and noncommercial, not under the control of
advertisers.  Instead, the priority was authorial
control: AO3 was designed to give creators the ability to post and edit their
works flexibly, to orphan their own works to preserve access to them without
connecting them to the author, and to exclude search engines or non-Archive
users from reading.
One of the most
distinctive features of the Archive is the curated folksonomy used to tag individual
works: “Users are able to tag in whatever format is most useful or natural to
them, and our team of over 350 tag wranglers link these tags together into
easily searchable concepts.”  If you
misspell Harry Potter’s name—or put it in kanji—we’ve got you covered.  Creators can use tags to allow other users to
find exactly what they want to see—or to exclude exactly what they don’t.
“[U]sers can easily create specific searches, including all Sherlock Holmes
works posted in 2018 that are exactly 221 words long and Lord of The Rings/Game
of Thrones crossovers that don’t include either Frodo Baggins or Arya Stark.” “Related
concepts are also linked: Space Opera and Space Battles are both found under
the metatag Outer Space, along with other related terms like Astronauts,
Spaceships, and even Space Whales.”
Fanworks provide incredible
benefits in literacy, sexuality education, language learning, community
building, and other good things that come from making something you love and
sharing it with other people who might just love it too.
On the content v.
tech distinction that Maria Strong made: we consider ourselves content folks
who use tech.  But importantly, we rely
on fair use: our basic purpose is to host transformative noncommercial works. Gives
us a particular perspective on various copyright controversies.  For example, recent Copyright Office report
on moral rights, which you’ve just heard about. 
The Office did a lot of good work pulling together the legal background
both internationally and in the US, covering many issues that go beyond
copyright into other regimes that affect authors.  A moral right of integrity that would protect
authors against uses of their works they found offensive would be incompatible with
US fair use and the First Amendment and the Office didn’t suggest any basic
changes to that system, to the Office’s great credit.
It is definitely
true that norms of fairness matter a lot in authorship, including attribution
in many circumstances—but not necessarily in the rigid categories formal law
might use.  For example, fans regularly describe
authors of books, but generally identify performers of songs rather than
songwriters. More generally, attribution practices in and out of fandom are
highly context specific—what works for one group might not work for
another.  Hollywood screenwriters have an
arbitration system for assigning credit that is often needed because fights regularly
break out.  Similarly, the Office pointed
out that, “in legal writing, attribution norms for academic articles are quite
rigid, whereas practicing lawyers routinely copy without attribution ‘the form
and language of legal instruments.’” Attribution turns out to be the kind of
inquiry that isn’t well suited to the American legal system, because modern
copyright statutes and regulations tend to make big, specific lists of required
information.  The Office wisely
recognized that antiplagiarism norms work about as well as anything can work,
and that the context of attribution would be essentially impossible to write
into law.
Nonetheless, and
without showing that there was a noticeable unmet need for new protections, the
Copyright Office has just suggested that the federal Lanham Act can &
should be used against unattributed copying of digital works, in defiance of
the Supreme Court’s decision in Dastar
and its own stance on digital first sale. 
[I should note I think the Office is completely right in saying (1)
§43(a)(1)(B) claims should survive Dastar
where false attributions are material to consumers and (2) Dastar applies to in-copyright works as well.  It’s just disingenuous at best in endorsing a
distinction between nondigital and digital copies that does not make sense of
the Supreme Court’s interpretation of “origin,” especially in light of the
Office’s (correct) position in discussions of first sale that a digital copy stored
on a computer is a reproduction.  The “origin”
of a digital copy is the host computer, and maybe stretching it could be the
sending computer, but there is a physical instantiation and that instantiation is
what the Lanham Act covers in “origin” under Dastar.  Specifically, the
origin of the creative work contained in that copy is not the same thing as the
origin of the physical copy, no matter whether the copy is on a general-purpose
computer, a videotape, or a DVD, and thus failure to attribute the origin of
the creative content is not actionable under §43(a)(1)(A) per Dastar.]
It also stated that Congress
might want to consider amending the Lanham Act to create new causes of action
to cover false representations regarding authorship of expressive works, even
without a showing of harm to consumers. The Office suggested amending the
Copyright Act to provide damages when a defendant knowingly removed or altered
copyright management information (“CMI”) with the intent to conceal an author’s
attribution information even if there was no intent to conceal infringement,
and possibly even adding a federal right of publicity.  In addition, the Office suggested some
changes to the more limited Visual Artists Rights Act. 
Aside from the
suggestions about VARA, the rest of the Office’s ideas are a classic case of proposing
to use a missile against a gnat—likely to the detriment of small and
noncommercial creators, who are the ones who can neither afford to bring claims
nor fight claims brought against them. 
And the specific suggestions lack exactly the kind of context
sensitivity the Office acknowledged was needed—for example, the proposed CMI
provision on its face makes it illegal for an app to remove identifying
information of people submitting anonymous videos of police brutality—and if
you think that enterprising prosecutors wouldn’t use this law against the ACLU,
you haven’t been paying attention.  [The
CO says that the intent requirement would mean that automated removal wouldn’t
be actionable unless it was designed to remove authorship information … but anonymous
reporting apps are designed to do that. And for what it’s worth, the complaints
the CO reported receiving about removing authorship information were mostly
about automated processes—the proposed remedy doesn’t even match the thing
that’s being complained about.]
It’s also worth
pointing out the solution that the Copyright Office didn’t suggest for congressional intervention: although its
discussion of authors’ rights mentioned attribution and integrity rights
secured by labor law and collective bargaining, both in the US and elsewhere,
the Office didn’t suggest that strengthening authors’ positions could be
achieved by strengthening the position of workers, even though the most
vulnerable authors are labor and not management.   The
problems the Office identified in securing attribution for certain groups, like
freelancers, are labor problems—authors after all make copyrighted works, and we should not allow the
concept of the “work” to disappear as if authors were mystical beings with no
connection to other forms of labor, other forms of production, that do things
in the world.  Our desire to highlight
the process of creation was in fact one of the reasons that we called our
nonprofit the Organization for Transformative Works: whether made for profit or
not, creative works are the product of labor. 
Remembering the inherent dignity of that labor, and its value whether or
not there is a market for the resulting creativity, is a goal that the OTW
shares with the Copyright Office.
Stacey Lantagne:
Internet Memes, Fanworks, and Copyright’s Authorship Challenges
Memes regularly
involve © works; one opinion expressed: the public “owns” the meme because the
public authors the meme even if not the underlying photo.  Fox defended an infringement case juxtaposing
9/11 and WWII images—court didn’t like the fair use defense b/c didn’t see the
transformativity, but it turns out that the range of “memes” is very
broad.  Knowyourmeme has no
definition.  When Trump (or a Trump fan)
adds CNN’s logo to a clip of wrestling so that it looks like Trump is beating
up “CNN,” that’s what’s adding the meaning especially after it’s been shared by
Trump himself. Similarly, Pepe the Frog became a white nationalist symbol and
created contests over ownership w/initial artist and those who altered it. Gab
now uses a frog logo and claims that frogs have been symbols of free speech for
a long time (narrator: they have not), and it’s a reference but not all that
similar to Pepe.  Then the distracted
boyfriend meme, which comes from a stock photo with a © owner, who is fine with
most uses but not w/objectionable ones (which may be censorial).  As the distracted boyfriend meme develops,
responses to it/reworkings of it are based on transforming the meme rather than
on the photo alone, which has become subsumed into the meme and the idea of the
meme. 
The internet thus
exposes that the mastermind narrative of single creation is wrong. We knew that
but dealt with it mostly by contract, and then we have this control test for
noncontractual situations but it still wrongly assumes that there is a “boss”
in control of everything. When you don’t have contracts, when you don’t have
lawyers, we don’t know what we’re doing in terms of ownership. Garcia v.
Google: opinions don’t make sense internally and are conflicting all over the
place.
Capitalism makes
everything worse/more exploitatitve: Swedish company used distracted boyfriend
meme for job searching and ad regulator called it sexist and said it couldn’t
be used in ads. There is a pending case against a MAGA poster by Pepe’s
original creator Matt Fury; there’s a fair use argument but also the defendant
argues that Fury abandoned the © (which is not a thing).  There’s a lot of unsettled territory here.
Hilary Richardson:
Google Open Source and Collaborative Authorship
Writing a casebook
on open source legal issues: opensource.google.com/docs/casebook: you can send
us edits or additions in a GitHub pull request. 
Current joint authorship standards give equal rights to all
authors.  Some projects list all
“authors” giving them shared control. Some may have 100% consensus, but for a
growing project that can be unsustainable, and some institutions may not want
the potential liability/disputes that comes from open source authors’ potential
for contestation.  Current doctrine
(Al-Muhammad etc.) looks for a mastermind—important contributions can still
avoid being authorial. Court was concerned about discouraging future
editing/feedback if joint authorship was a possible consequence. Creative
control/direction mattered, versus value of contributions and impact on final
version. Spike Lee had the control (although it was a work for hire) and the
court found that determinative.  Other
jurisdictions also use editorial control over final piece as part of the test,
but with more focus on intent to be co-author. 
Control can be evidence of intent, but intent could also be evidenced
by, e.g., registering the © in a person’s name.
Clarity can come
from legal agreements: two popular mechanisms, developers’ certificate of
origin (Linux) which doesn’t say anything about retaining © but does grant an
explicit license.  Is everyone a joint
author?  Contributor license agreement:
says that © stays with contributor but they grant a license.  That makes it clear that people aren’t
considered joint authors.  More
light-weight approaches: root license of a project is used to cover
contributions. Can be used to imply effects on individual contributions;
sometimes licenses say “if you contribute, you do it on these terms.”  The
Stuff
case about contributing special effects to a larger film: helps
explain the effects of an implied license to use a contribution.
Katrina Geddes:
Should User-Generated Content Be Compensated?
UGC: just about
everything you find on the internet.  Childish
Gambino’s
This is America was a canrivalesque commentary on police
brutality, fetishization of black performers, modern-day minstrelsy. People
responded w/, e.g.,
This is Nigeria: commentary on police brutality, corruption,
poverty, Boko Haram, and other Nigerian issues. Similar music and choreography
but different lyrics (both set in warehouse). 
Why do we value things like fan fiction? 
People get to see themselves where they don’t get to see themselves in
mainstream works: LGBTQ people, people of color. Challenge racial and social
assumptions of mainstream works; challenge the monopoly on cultural production
of large producers. Can also maintain the cultural relevance of works, such as
maintaining interest in the Star Trek
universe.  Satisfies demands for
variation and personalization, rather than works manufactured for a huge
audience. Democratizes creativity—authorship is diverse and diffuse.  Meme authorship can often be indeterminate. 
Content ID: used
algorithmically mostly for commercial content. 
400 hours to YouTube uploaded per minute. Fanmade videos for Harlem
Shake were matched to the song, allowing the song © owner to generate millions
of revenue with no allocation between the music and the video created by fan
labor. Under 1% of Content ID matches are disputed.  Fair use can’t reliably be done by
algorithms; Content ID is black box governance, unaccountable—even when the
uses removed or monetized may be perfectly lawful.  Expands scope of © by making it difficult for
users to rely on exceptions like fair use.
Locke and labor
theory: just reward of labor should extend to fan creations that are
monetized.  Eric Posner etc. have argued
that not just UGC but our labor online, clicking and producing valuable data,
should be understood as compensable.
Canadian UGC
provision: protects UGC made by an individual, though there’s usually more than
one author.  Also protects UGC only when
© subsists, which bakes in originality. 
Requires noncommerciality—no pro-rated advertising revenue.  Also bars anything with a vague, broad
“adverse effect, financial or otherwise” on the © owner—that could include
offending the original © owner.
Should users be compensated?  The labor
of users should be recognized and respected, and possibly compensated. But
commercialization is part of the fair use inquiry; it may weigh against fair
use.  Commercialization may result in
reduction in expressive diversity: anticipation of paid markets may affect
content and willingness to participate/be spontaneous in creativity.  Distinguishing when compensation would be
paid would require resources, negotiation in allocation between different
owners. Right now it’s 100% to the original claimant, but other points on the
spectrum are possible. Don’t just assume that everything with a match should be
100% monetized by the © owner.  We could
ask users to categorize their works to claim a share; this would allow more
information and an algorithm could at least look for percentages/set things up
for human review.
Q: fair use is
important; from litigator’s perspective, one downside is expense to
determine.  Oh, the Places You’ll Boldly
Go! was found to be fair use on summary judgment, but not at the MTD stage
which was 1½ year earlier.  Is there a
way to get to fair use faster?  Market
harm may require discovery—that’s the most expensive part of most lawsuits.
RT: sadly, not a
lot.  There are uses that are fair as a
matter of law, including parodies.  Big
data, purpose-transformation uses are for better or worse somewhat easier to
identify as fair use as a matter of law. 
Sometimes you are going to have to evaluate the transformativeness of an
individual work.  [We can have rules that
help, like the Second Circuit’s rule that you can’t avoid a fair use finding by
offering  a license for something that is
in fact transformative—that helps draw the sting of some market evidence.] Small
claims: 40% of Americans can’t come up with $400 for an emergency.  A “small claims” court that allows $30,000 in
statutory damages is not a small claims court. It’s just another way to harass
individuals.  [I forgot to add: best
practices in fair use for different fields—also very helpful.]
Lantagne: education,
nonprofits like OTW/EFF.
Geddes: Canadian UGC
exemption needs some time to develop. 
Education is also important.  People want rules like “30 seconds is ok.”
Richardson: people
do want rules: are 3 lines of code ok? 
Depends on what the 3 lines are!
Kimberly Isbell:
proposed 1202A.  The reason we made it a
new provision is b/c it’s narrower and specifically exempts criminal
enforcement.  The only person who could
bring a claim would be the uploader. The ACLU has terms of use: if you provide
content it will be anonymous.
RT: Disagree.  The statutory language is “any person injured
by a violation,” and the police will say they’re injured by the inability to
investigate the circumstances under which the video was taken further.  The injured person doesn’t have to be the
author (or heirs) under this proposal.  There
is a long tradition of (mis)using civil awards to silence speakers, e.g. NYT v.
Sullivan.  The proposal does not exempt
information submitted by someone who wants to be anonymous or who doesn’t know
or care about stripping of metadata [nor does it limit enforcement to the
author, which would also be a potential fix, though I still don’t see the
evidence that an additional cause of action is needed].
Q: software should
just be patentable, not copyrightable.
Richardson: the law
says copyrightable and she’s ok with that.
Q: memes &
defamatory content. There are a lot of really awful Helen Keller memes out
there.  What should happen when there’s a
historical figure & derogatory content.
Lantagne: a lot of
times people bring © claims that should be more personal tort based.  She hasn’t come across non-© meme cases, but
she wasn’t specifically looking for them. 
Unless publicity rights outlast death, there are few remedies for the
dead.
Richardson: revenge
porn is an example of where © was deployed even though it wasn’t intended for
those situations; you shouldn’t need to register an explicit photo to deal with
the problem of revenge porn, and new laws and platform policies are recognizing
that.

from Blogger http://bit.ly/2w0dDWh

Posted in Uncategorized | Tagged , , , , , | Leave a comment

CopyrightX summit: Keynote by Maria Strong

CopyrightX summit
Keynote: Maria
Strong, Director of Policy & International Affairs, U.S. Copyright Office
Update on elements
of protection, exceptions/permissible uses. 
Biggest news in 20 years: Music Moernization Act, including many
recommendations from the CO.  Blanket
license for digital music providers: new way for tech platforms and music
providers to unite online. CLASSICS Act: pre-72 recordings partially into the
federal © system, with some exceptions/limitations.  Requires a lot of rulemaking by CO, including
exceptions for noncommercial use and designating licensing coordinators.  New spirit of cooperation and momentum in
Washington.  Could this lead to more
openness to action on things like felony streaming of infringing public
performances?  That died along with SOPA
but maybe there’s an appetite for it now, or for something on small ©
claims.  $350,000 is average ©
litigation.  New legislation was just
introduced in House and Senate on small claims.
DMCA: continue to
work on policy study examining effectiveness of §512.  92,000 comments received and several
roundtables.  Often oversimplified by 2
sides.  Content folks feel 512 is broken
and tech feel its fine. Large content providers have different concerns than
small providers, and so too with tech companies. Many different kinds of users.
Moral rights: 30
years since we joined Berne under a “patchwork” of moral rights. Tech changes, Dastar, state law changes, new int’l
treaties chane things.  Did notice &
comment.  Report identified key
principles: maintain First Amendment & fair use, copyright’s limited term,
importance of attribution to creators. US legal framework provides important
protection, but there’s room for improvement if Congress wants.  Identifies several legislative paths:
amending the Lanham Act; VARA fixes; §1202 copyright management tweaks in new
1202A; federal right of publicity.
Proposed changes to
Compendium of office practices; currently seeking comments. Also post review
letters for appeals from denial of registration.  And we’ve prepared a Fair Use index:
summaries of over 200 fair use cases, searchable by court and type of
work. 
Int’l: WIPO.
Broadcasting Treaty negotiations, going on for more than 20 years at WIPO.  US supports a signal-based approach to the
treaty. More guidance coming in October. 
Second, IGC (intergovt’l committee) tackling connections b/t cultural
identity and mobility. Current focus: distinction b/t traditional knowledge and
traditional cultural expressions and possibility of different treatment of
those.  Most important politically:
decide on recommendation on scope of group’s mandate.
Activities related
to exceptions/permissible uses: Marrakesh Treaty was adopted rapidly.  US amended law to comply, last October, just
in effect on May 8.  From nondramatic
literary works, expanded coverage. New 121A deals with export and import of
accessible works by authorized entities.
1201: Policy study
to streamline the process, which is long/arduous [co-signed!].  Proposed some streamlining for renewals of
unopposed exemptions, which was implemented. Split process into looking at unopposed
v. new proposals/data. Many of the new exemptions built on prior rulemaking.
Recommended 9 classes for exemptions. 20% faster than previous. 329 pages this
time versus 400+ last time.  It’s a
fulltime yearlong process; we realize it’s challenging for participants.
MMA: permits
unoncommercial uses of pre-72 sound recordings not being commercially exploited
under certain circumstances.  CO now
accepts Notices of Noncommercial Use: document users can file to become
eligible for safe harbor. CO doesn’t verify information in NNU.  User has to conduct good faith, reasonable
search & rightsowner must not object w/in 90 days of filing of NNU.  Detailed instructions for good faith search:
example—for recordings of recognized Alaska Native or American Indian tribes,
search must be done through contacting the relevant tribe, association, or
holding institution.
Section 108:
discussion document stating CO’s belief that 108 needs revision for libraries
and archives.  Wanted a framework for
further discussion among stakeholders and Congress: preservation,
security.  CO provided model statutory
language to jumpstart the discussion.
Working on better
public access to records. Digitized over 41 million © card catalogs, 1870-1977.
Now browsable. MMA outreach: we have tutorials, dedicated website,
participation in events around the country.
Q re digitization: did
you get everything?
A: we got all of one
type of record, but there are 2 other types we’re digitizing.
Q: museum
exceptions?
A: a major
modification we’d like to make is to include museums specifically, not just
libraries/archives.
Q: moving CO out of
Library of Congress?
A: awkward Q! Two
years ago, there was uncertainty when Register left and House passed a bill to
make the Register a Senate appointed position. That didn’t pass and hasn’t been
reintroduced. Near future: that issue is probably not going to be engaged.  [I think there’s a huge separation of powers
issue in giving the CO rulemaking etc. powers as an entity in the legislative
branch but that’s not a political or policy question in the ordinary sense and
there’s no reason Strong needs to have a position on it.]

from Blogger http://bit.ly/2Q0dR92

Posted in Uncategorized | Tagged , | Leave a comment

She don’t lie, but the pharmaco might: cocaine false advertising case continues

Genus Lifesciences Inc. v. Lannett Company, Inc., 2019 WL
1981186, No. 18-cv-07603-WHO (N.D. Cal. May 3, 2019)
Genus competes with Lannett in the market for cocaine
hydrochloride nasal spray. It sued Lannett for false advertising and
maintaining a monopoly related to Lannett’s production of C-Topical, a cocaine
hydrochloride solution that competes with Genus’ own cocaine hydrochloride
solution, Goprelto. At its core, the complaint alleged that Lannett falsely advertised C-Topical as FDA-approved. Genus also sued First Databank, “a pricing list company
that compares drug products and their prices so that wholesalers and customers
can see all the alternatives available for a particular medication,” for false
advertising and contributory false advertising. Here, Judge Orrick declined to
dismiss all claims against Lannett, but kicked First Databank out because its challenged
statement in the pricing list was not “commercial speech” and First Databank
did not influence Lannett’s alleged false advertising.
  
In 2017, the FDA granted approval of Goprelto’s New Drug
Application, which required five clinical trials and ten non-clinical trials
involving over 700 human subjects. The FDA approved Goprelto “for the induction
of local anesthesia of the mucous membranes when performing diagnostic
procedures and surgeries on or through the nasal cavities in adults.” “As the
first FDA approved cocaine product, Goprelto was awarded new chemical
exclusivity, which bars any third-party applicant from seeking FDA approval
until December 14, 2022.”  C-Topical and
Goprelto have the same active ingredient, the same strength, and the same
dosage form, and are interchangeable for certain medical uses, including
Goprelto’s approved indicated use.
As the court explained, legal marketing of drugs in the US
requires approval of an NDA or ANDA or exemption from the NDA requirement.  Exemptions include “grandfathered” drugs and
drugs subject to an ongoing drug efficacy study implementation proceeding. A
drug is grandfathered if, among other requirements, its composition and labelling
have not changed since 1962. In 2006, the FDA stated that in cases where one
drug was approved but had unapproved competitors, there would generally be a
grace period of one year before the FDA initiated enforcement action against
the unapproved drug, but the FDA hasn’t yet acted against Lannett.
C-Topical has been on the market at least since 2008, and
Lannett was the sole supplier of cocaine hydrochloride solution products to ear,
nose and throat doctors from 2012 until Genus’s launch of Goprelto. In 2015,
the FDA rejected Lannett’s request that C-Topical be grandfathered. Despite
that, Lannett claimed that C-Topical was grandfathered in a number of SEC filings
and investor calls in 2017 and 2018. Lannett also allegedly advertised C-Topical
as being legally marketed under a “preliminary new drug application” in a
number of SEC filings, “a fictitious regulatory category.”
In addition Lannett’s meta description for its C-Topical
webpage states, “Learn more about the facts and characteristics of the generic
pharmaceutical C-Topical® Solution CII,” although C-Topical is not a generic
pharmaceutical product because it does not have an approved ANDA.
Lannett also allegedly intentionally misled customers by
making the product packaging look like an approved FDA drug, maintaining a
website with the package insert information that looks like an FDA-approved
insert, and registering a trademark for C-Topical. 
Lannett’s website also allegedly “identifies it as a generic
pharmaceutical manufacturer whose leadership is committed to adherence to FDA
standards and compliance with regulatory requirements,” as does its subsidiary
Cody’s, but both sites list C-Topical as one of their products. In addition,
Lannett advertised C-Topical as a “topical solution … indicated for the
introduction of local (topical) anesthesia of accessible mucous membranes of
the oral, laryngeal, and nasal cavities.” This allegedly falsely implied that a
cocaine hydrochloride solution product has been approved by FDA for oral or
laryngeal uses, when no such product has ever been approved in that way. This
allegedly further misled customers into believing that C-Topical had more uses
than Goprelto, making it a more desirable and better product.
Lannett also allegedly provided incomplete or false
information to third party intermediaries in the supply chain of pharmaceutical
products. For example, Lannett sold C-Topical to McKesson Corp., a wholesaler whose
website indicated that C-Topical is generic and does not state that it is
unapproved by the FDA. Intermediaries rely on companies that aggregate
third-party drug pricing information, such as First Databank. “These companies,
including First Databank, assign unique identifying codes for each drug,
allowing for price comparisons of equivalent products.” Because Lannett didn’t
identify C-Topical as unapproved, intermediaries were allegedly unable to
accurately describe it. Genus cited “a study that states that in a nationwide
survey of pharmacists, 91% thought all products pharmacists dispense are FDA
approved.” Customers were allegedly misled to believe that C-Topical is FDA
approved and choose to purchase C-Topical over Goprelto on that basis.
First Databank allegedly assigned a unique clinical
formulation ID (CFI) to drugs based on ingredients, strength, dosage form, and
route of administration. Drugs with the same attributes were assigned the same
CFI and “linked” so that a search for one would produce the other as a
substantive alternative. But, since C-Topical’s route of administration is
listed as “topical” and Goprelto’s is listed as “intranasal,” the two drugs are
given different CFI numbers. Consumers would allegedly be misled into thinking
that C-Topical is the only cocaine hydrochloride drug available on the market. Genus
allegedly notified First Databank about the misleading advertisement, providing
First Databank with knowledge.
Genus also alleged anticompetitive conduct in the market for
cocaine hydrochloride solution, which is allegedly unique because it is the only
nasal product that is both a vasoconstrictor and local anesthetic, unlike any
other drugs on the market. Lannett allegedly schemed to use a different CFI
number to prevent the parties from competing on price. “But because the CFI
numbers are different, and C-Topical had a monopoly on the market for a number
of years, customers are generally not aware that Goprelto exists and will not
find it when searching for or reordering C-Topical.” Between June 2018 and
September 2018, Genus sold only 544 bottles of Goprelto while Lannett sold over
45,000 bottles of C-Topical, despite Goprelto’s lower price.
“Lannett’s core argument is that absent an affirmative
representation of approval, marketing an unapproved drug is not actionable
under the Lanham Act.” It’s not enough to put an unapproved drug on the market
with a FDA-ish package insert, according to Mylan Labs., Inc. v. Matkari, 7
F.3d 1130 (4th Cir. 1993). Genus pointed out that the Lanham Act covers more than
affirmative, literally false statements. Par Sterile Prod., LLC v. Fresenius
Kabi USA LLC, No. 14-cv-3349, 2015 WL 1263041, at *4 (N.D. Ill. Mar. 17, 2015),
agreed that mere alleged implication that a drug was approved by the FDA was
insufficient to state a Lanham Act claim, but also found that the implication was
enough when combined with allegations that (i) buyers believe all prescribed
drugs identified on the Price Lists are FDA approved and (ii) that in some
surveys 91% of pharmacists are actually confused about whether all drugs that
appear on industry price lists are approved. This was enough to survive a
motion to dismiss, though not necessarily to survive summary judgment.
What about the false statements in SEC filings and investor
calls?  [As Matt Levine of Money Stuff
says, sounds like securities fraud because everything is securities
fraud.]  That didn’t seem like
“commercial advertising or promotion.” Genus failed to allege “that the SEC
statements and investor calls were made for the purpose of influencing
consumers to buy its goods or services, or that they were disseminated
sufficiently to pharmacists, doctors, and hospital groups.”
And the cases were on Lannett’s side. For example, Sigma
Dynamics, Inc. v. E. Piphany, Inc., No. 04-cv-0569-MJJ, 2004 WL 2648370 (N.D.
Cal. June 25, 2004), held that in order for statements on the investor calls to
be actionable, “plaintiffs would need to allege that consumers attended the
investor conference calls and that the purpose of the investor calls was to
influence customers to buy defendant’s goods or services.” Sigma did hold that statements on websites and in press releases
available to the public were commercial speech for purposes of a motion to
dismiss, but Judge Orrick disagreed [he didn’t really disagree, he just thought
that commercial speech was a broader category than “commercial advertising or
promotion”]: “in order to be actionable, the statements must be accompanied by
specific allegations that they were made for the purpose of influencing the
customers of cocaine hydrochloride solutions to buy C-Topical, or were
disseminated sufficiently to the relevant purchasing public (pharmacists,
hospitals, and doctors) to constitute ‘advertising’ or ‘promotion’ within the
pharmaceutical industry.”
Alleged falsity of labeling for oral, laryngeal, or nasal
administration: Lannett argued that the mere fact of broader labeling than
Genus wasn’t actionable, and that there were no false comparative
statements.  But the FDA says that a
“topical” route is “[a]dministration to a particular spot on the outer surface
of the body[.]” Lannett’s label states that C-Topical is “indicated for the
introduction of local (topical) anesthesia of accessible mucous membranes of
the oral, laryngeal and nasal cavities.” Mucous membranes are not the outer
surface of the skin; this affirmative misrepresentation allegedly harmed Genus
by inducing customers to believe that C-Topical is different and superior to
Goprelto because of its additional routes of administration. The court agreed
that this was sufficiently pled.
Failure to affirmatively disclose unapproved status to third
parties and intermediaries: Lannett argued that it had no duty of disclosure
under the Lanham Act. It also argued that the materials it sent to the third
party intermediaries explicitly state that C-Topical lacks FDA approval and the
product information on First Databank and other price lists made this clear as
well.
Genus didn’t state a claim for false advertising to price
lists and other third party intermediaries because there are weren’t supporting
allegations, such as the surveys Genus cited for pharmacists. The court
commented that an allegedly “buried” disclosure would “support a finding that
Lannett has correctly informed the price lists,” which I don’t quite get—is it
not plausible that price list operators would miss fine print?  Seems like an odd thing to say on a motion to
dismiss, but perhaps the court just wanted that spelled out in the allegations.
Website statements: Lannett argued that the meta description
on its C-Topical website describing the drug as generic wasn’t misleading, read
in context with Lannett’s landing page that states that the FDA has not
approved C-Topical. But Genus alleged that the landing page didn’t say that.
Instead, one had to click on a “package insert” link.  While initial interest confusion cases say
that a landing page can dispel potential trademark confusion, Lannett’s landing
page “would not disabuse a consumer of the notion that C-Topical is generic
based on the meta description.” Thus, the allegedly false statement in its
website’s meta description could be the basis for a false advertising claim
under the Lanham Act. [The court doesn’t discuss whether the description was
visible in search results—for what it’s worth, when I searched Lannett’s
current page didn’t use the term “generic.”]
General statements on Lannett’s websites about FDA
compliance: Lannett argued that its statements weren’t specific to C-Topical
and that compliance with FDA requirements was within the FDA’s primary
jurisdiction. Genus responded that Lannett’s website makes no carveout for
C-Topical and that because the FDA denied Lannett’s application to grandfather
C-Topical, Lannett’s statement of legal compliance was false.  The court found that Genus’s argument
stretched the FDA’s denial too far. The FDA rejection didn’t explicitly say
that C-Topical couldn’t be marketed, only that it couldn’t be described as
“grandfathered.”
The court turned to statements about making compliant,
generic products, e.g., “[i]t’s important to remember that generic medicines
are made to meet the same standards, as provided by FDA, as brand name
medicines. Customers may rest assured that generic pharmaceuticals are produced
with the same active ingredients and attention to quality as branded versions.”
Those weren’t false, and Genus didn’t plausibly allege that the statements
actually conveyed the implied message that C-Topical was grandfathered or sold
with FDA approval, and deceived a significant portion of recipients.
However, on subsidiary Cody’s website, the statements that “Cody
Laboratories is committed to compliance with all Local, State, and Federal
requirements and regulations governing our business, especially FDA, DEA …”
and that Cody’s “active pharmaceutical ingredients are used in FDA approved
commercial drug products,” combined with its identification of “Cocaine
Hydrochloride USP” as one of those ingredients plausibly added up to an
affirmatively false or misleading statement. Genus sufficiently alleged
materiality: “FDA approval status of a prescription drug is material to
customers because approved drugs provide customers assurance as to the quality
of the product not afforded to unapproved prescription drugs.”
Appearance and content of C-Topical’s labeling and
packaging: Resembling FDA-approved drug packaging wasn’t enough to plausibly
allege deception. There weren’t sufficient allegations of intentional deception.  “[W]hen the alleged representation is not an
overt false statement but is merely misleading in context as it is here, the
pleading standard is higher and allegations that the advertising actually
conveyed the implied message and deceived a significant portion of recipients
is required.” Genus made only conclusory statements such as, “On information
and belief, Lannett’s and Cody’s packaging and packaging insert deceives, or
has the capacity to deceive, a substantial segment of customers, including
pharmacists, into believing that Lannett’s and Cody’s C-Topical has FDA approval.”
More specific allegations were mandatory without an affirmative misstatement.
The antitrust claims failed because they were antitrust
claims. Specifically for the false advertising part, even though Genus
adequately alleged that the statements were (1) clearly false, (2) clearly
material, (3) clearly likely to induce reasonable reliance, and (4) made to
buyers without knowledge of the subject matter, that’s not enough to avoid a
presumption that the effect on competition was de minimis.  The false advertising must also have (5)
continued for prolonged periods, and (6) not have been readily susceptible to
neutralization or other offset by rivals, and Genus didn’t allege those. It
wasn’t enough to allege that “Lannett makes it prohibitively difficult for customers
to find a competing product,” and that “customers” tend to repeat their last
order or search directly for [C-Topical],” making it difficult to rebut the
false promotions. It also alleged that “[w]holesalers, GPOs, and IDNs use, or
rely upon, First Databank’s CFI codes to compare products” making other
marketing methods less useful.  “But
these allegations do not show why other efforts to promote its product, other
than its attempt to get First Databank to change C-Topical’s CFI number, have
failed or would not be successful,” e.g., an ad campaign touting Goprelto as
the only FDA approved cocaine hydrochloride product, or efforts to educate
customers that C-Topical is unapproved or that its route of administration is
misleading.
California FAL and UCL claims survived because the Lanham
Act claim did.
First Databank: Genus sued for false advertising of
C-Topical as having a “topical” route of administration and for contributory
false advertising based on Lannett’s primary conduct.
Direct false advertising: this wasn’t commercial advertising
or promotion as to First Databank because the price list wasn’t meant to
influence purchasers to buy First Databank’s goods or services; it was what First Databank sold. Although
the Gordon & Breach test for
“commercial advertising or promotion” likely needed modification after Lexmark to remove the requirement of
speech by a competitor, that didn’t
affect the outcome here.
Genus argued that First Databank wasn’t a “mere reference
database” because it derives millions of dollars from licensees to access the
pricing list and that it failed to identify any statements of public importance
that would make the pricing list non-commercial speech. Customers allegedly relied
on pricing lists for the purely commercial purpose of comparing products and
prices. Still, under Bolger, First
Databank’s pricing list didn’t propose a commercial transaction between First Databank and customers of cocaine
hydrochloride. Genus didn’t allege that First Databank had a monetary interest
in whether customers chose C-Topical over Goprelto. Though Genus argued that
“First Databank’s business involves a quid pro quo in which information is
provided to First Databank in exchange for First Databank utilizing the data,
including assigning its own CFI codes, and targeting and distributing it to the
relevant consumers,” that “would be true for every drug listed on the pricing
database, including Goprelto, and cannot reasonably be characterized as a quid
pro quo relationship for the purposes of this case.” Although First Databank allegedly
had an economic motivation to make representations about specific drugs in
order to maintain its market position in the pharmaceutical supply chain, that
didn’t show a profit motive in any particular representation.
Contributory false advertising: Genus argued that First
Databank contributed to Lannett’s alleged false advertising by knowingly and
materially participating in it. The court thought that contributory false
advertising couldn’t apply to non-commercial speech in any context because “the
Lanham Act, as a whole, applies only to commercial speech.”  [Side note: hotly contested or just wrong on
the TM side of the Lanham Act!  But to
the extent that we’re talking about contributory liability, we may be talking
about acts that are not even commercial speech, like ordinary contractual
language or other economic activity carried out through speech.]
Out of an abundance of caution (and perhaps an eye for
interesting arguments), the court analyzed contributory false advertising
without reference to commercial speech. In Duty Free Ams., Inc. v. Estée Lauder
Cos., 797 F.3d 1248 (11th Cir. 2015), the Eleventh Circuit held that
contributory false advertising requires a showing of (1) direct false advertising
by a third party and (2) defendant’s contribution to that conduct “either by
knowingly inducing or causing the conduct, or by materially participating in
it.” Genus satisfied (1) but not (2). 
Material participation, analogizing from trademark, can occur
where a defendant directly controlled or monitored the third party’s false
advertising, or maybe even when the defendant provides a necessary product or
service without which the false advertising would not be possible. The Eleventh
Circuit suggested looking at “the nature and extent of the communication”
between the third party and the defendant regarding the false advertising;
“whether or not the [defendant] explicitly or implicitly encouraged” the false
advertising; whether the false advertising “is serious and widespread,” making
it more likely that the defendant “kn[ew] about and condone[d] the acts”; and
whether the defendant engaged in “bad faith refusal to exercise a clear
contractual power to halt” the false advertising. Genus’s allegations didn’t
meet this standard. “The allegations in the complaint do not suggest that First
Databank’s conduct was persuasive in inducing Lannett to do what it did.”
First Databank pointed to the test used in ADT Sec. Servs.,
Inc. v. Sec. One Int’l, Inc., No. 11-cv-05149-YGR, 2012 WL 4068632 (N.D. Cal.
Sept. 14, 2012), which held that a claim for contributory false advertising
requires that the defendant: “(1) intentionally induced the primary Lanham Act
violation; or (2) continued to supply an infringing product to an infringer
with knowledge that the infringer is mislabeling the particular product
supplied.” Under that test, Genus’s claims also failed.  The tests were different, but they had the
same theory: “the party accused of contributorily infringing essentially drives
the infringing party’s conduct.” Genus’s theory was the opposite. Its
contributory false advertising claim against First Databank was dismissed with
prejudice.

from Blogger http://bit.ly/2PVvlTX

Posted in Uncategorized | Tagged , , , | Leave a comment

Patent grants and gender bias

Spotted via Colleen Chien, on patents and gender bias:

The researchers found that women inventors with common names
had an 8.2% lower chance of getting their patents approved. But the difference
in probability of approval fell to 2.8% for those with rare names, where it
would be tougher for an examiner to guess the applicant’s gender.
When it came to future citations, patents that listed common
female names were cited 30% less frequently than those held by people with
common male names. That disparity did not simply vanish for women with rare
names; it actually reversed. Their patents were cited approximately 20% more
frequently than patents listing rare male names.

from Blogger http://bit.ly/2vJFEkV

Posted in Uncategorized | Tagged , | Leave a comment

Journal article merited better disclosure of affiliation w/competing group, not a lawsuit

Board of Forensic Document Examiners, Inc. v. American Bar
Ass’n, — F.3d —-, 2019 WL 1930310, No. 18-2653 (7th Cir. May 1, 2019)
The Board of Forensic Document Examiners is a non-profit
organization that certifies forensic document examiners (currently about 12),
who analyze and compare handwriting and provide expert testimony in judicial
proceedings. Thomas Vastrick, a forensic document examiner certified by a
different, much larger organization (the American Board of Forensic Document
Examiners), wrote an article in The Judges’ Journal, a peer-reviewed scholarly
journal published by the ABA. Vastrick’s article offered guidance for judges in
evaluating the qualifications and credentials of handwriting experts. He urged
judges to look for experts certified by the American Board and warned judges to
“be wary of other certifying bodies.” His biography identified him as a “board
certified forensic document examiner out of Orlando, Florida, with over 37
years of experience,” including service as chairman of the “Questioned
Documents Section of the American Academy of Forensic Sciences” and
participation in a handwriting study funded by the National Institute of
Justice.
The Board asserted claims of defamation per se and invasion
of privacy on behalf of all of its members, as well as civil conspiracy, false
advertising under the Lanham Act, and violations of state competition laws.  The specifically challenged statements:
“An appropriately trained forensic
document examiner will have completed a full-time, in-residence training
program lasting a minimum of 24 months per the professional published standard
for training. Judges need to be vigilant of this issue. There are large numbers
of practitioners who do not meet the training standard.” “The American Board of
Forensic Document Examiners … is the only certification board recognized by
the broader forensic science community, law enforcement, and courts for
maintaining principles and training requirements concurrent with the published
training standards. Be wary of other certifying bodies.” The article cautioned
judges “to look out for” examiners “[c]ertified by [a] board other than the American
Board of Forensic Document Examiners.” The article also cautioned against any
“[m]ember of American Academy of Forensic Sciences but not the Questioned
Document Section.”
The Board alleged that these statements misled readers about
the qualifications of its certified examiners. First, the professional
standards allegedly require only the equivalent of a 24-month full-time
training program, not a full-time, in-residence program as such. The second and
third statements, which identified the American Board of Forensic Document
Examiners as the only reputable certifying body, allegedly falsely implied that
the plaintiff’s members were unqualified, even though, like the American Board,
the Board is accredited by the Forensic Specialties Accreditation Board. And
Vastrick allegedly harmed one person in particular by warning judges about
forensic examiners who are members of the American Academy of Forensic Sciences
generally but not the American Academy’s Questioned Document Section
specifically; this person apparently is the only examiner who fits this
description.
The Board argued that these statements were defamatory per
se because they falsely imply that its experts do not meet the published
professional training standards for forensic examiners. “But not all statements
that doubt or impugn an individual’s professional abilities are actionable.” Opinions
are nonactionable, even if they concern the topics covered by defamation per
se.
Context showed that the statements were opinion, not
verifiable facts. The article appeared in a scholarly law journal, in an issue
devoted to “Forensic Sciences—Judges as Gatekeepers.” Anyone who read it would
understand that this was “but one practicing expert’s view on how judges should
attend to their gatekeeping obligations.” “Nobody reading the article in this
context could reasonably have seen Vastrick’s statements as assertions of fact
subject to falsification.”  This is
especially reasonable because the Journal warned readers that “[a]rticles
represent the opinions of the authors alone” and “provide opposing views” for
readers to consider. Vastrick also used the language of opinion: “I, as a
practicing forensic document examiner, would like to respectfully suggest ways
to differentiate between the true professional and the lesser-qualified
practitioners.” A label isn’t enough, but it helps the context.
Breaking down the statements also revealed their opinion
status.  For example, Vastrick discussed
the qualifications of “an appropriately trained forensic document examiner.” “This
express qualification—’appropriately trained’—signaled that Vastrick was
offering his own view on adequate qualifications for a forensic examiner, not
describing factual, objective standards for qualifications.” The assertion that
the American Board “is the only certification board recognized by the broader
forensic science community, law enforcement, and courts,” “likewise reflects
the expression of a viewpoint, as the statement is so broad as to lack
objective, verifiable meaning.”  It’s
true that Vastrick should in a moral sense have disclosed his affiliation with
the American Board in the article, but that didn’t make his statements
defamatory.
This conclusion also disposed of the Lanham Act claim.

from Blogger http://bit.ly/2PPWurq

Posted in Uncategorized | Tagged , , , | Leave a comment

Copying before-and-after surgical photos can be false advertising despite Dastar

Aesthetic Associates, Inc. v. Key West Institute for Plastic
Surgery, Inc., No. 18-10059-CIV-MARTINEZ-OTAZO-REYES, 2019 WL 1922854 (S.D.
Fla. Feb. 5, 2019)
Plaintiff, whose principal is Dr. Portuese, sued defendants
for copyright infringement, removal of CMI and false advertising in passing off
Dr. Portuese’s surgical results as their own. A patient consented to
before-and-after pictures of a rhinoplasty, to be posted on Portuese’s
websites; plaintiff registered the copyright.
Defendants allegedly posted the same before-and-after
patient photographs on their social media accounts in a manner that attempts to
pass off Portuese’s surgical results as those of defendants.
Defendants said Dastar
barred the claim; the court disagreed. 
Plaintiffs alleged the use of copyright photos with false
representations of fact “in a manner likely to cause confusion and deceive the
public into believing Dr. Loessin performed the surgery depicted in the
before-and-after patient photographs and that he can obtain those results.”  That was enough to state a claim for reverse
passing off.  It wasn’t just a restated
copyright claim.  [Less convincingly, the
court distinguishes Dastar because
the copyright here isn’t expired—irrelevant—and because defendants didn’t
“manufacture” the photo at issue, but of course they did “manufacture” their copy; the whole point is that they
made an unauthorized copy, but didn’t “make” the expressive content of their copy. 
The court should have rested on its better reasons.]

from Blogger http://bit.ly/2WrQ7gF

Posted in Uncategorized | Tagged , , , , | Leave a comment

court rejects contributory false advertising under Lanham Act

Telebrands Corp. v. My Pillow, Inc., 2019 WL 1923410, No.
18-CV-06318 (N.D. Ill. Apr. 30, 2019)
Telebrands sued My Pillow (maker of a “patented pillow
product,” which I’m so tempted to call PPP) for breach of contract, breach of
implied contract, tortious interference with business expectancy, unjust
enrichment, and quantum meruit. My Pillow counterclaimed for false advertising
in violation of the Lanham Act, violations of the Illinois Uniform Deceptive
Trade Practice Act (IUDTPA) and the Illinois Consumer Fraud and Deceptive
Business Practices Act (ICFA), unfair competition, fraud, and breach of contract.
Here, the court dismisses some of the counterclaims.
The counterclaim alleged that My Pillow and Telebrands
entered into a License Agreement under which My Pillow had the right to market
its pillows directly to consumers and Telebrands had the exclusive right to
“advertise, promote, market, distribute, and sell” the My Pillow pillows in
certain stores. The License Agreement required Telebrands to comply with all
applicable laws in performing under the License Agreement, including the FTC
Act. It automatically terminated by its terms in 2014, but the parties
continued their business relationship through a series of purchase orders.
After that time, Telebrands allegedly agreed not to engage
in false advertising of the My Pillow product and to prevent its retail clients
from engaging in false advertising, but didn’t. 
For example, in September 2018, Walgreens.com allegedly listed My
Pillow’s product as “Telebrands My Pillow” and showed a box image that
contained an endorsement of the product as “National Sleep Foundation Official
Pillow.” But My Pillow was, at the time, subject to a consent decree that
prohibited My Pillow from making any health claims about its product or
advertising it as an “official” product of any organization. Although it
informed Telebrands of the decree, and Telebrands agreed to ensure that its
retail clients remove from its advertisements all health claims and/or
statements that My Pillow is the “official” pillow, Telebrands allegedly failed
to monitor its retail clients’ advertisements to ensure the retailers complied
with My Pillow’s directives. My Pillow’s CEO allegedly met with a Telebrands
representative and showed them examples of false advertising from Telebrands’
retailers. The rep then offered to indemnify My Pillow for any damages incurred
from the false advertising.
Telebrands also allegedly agreed to prohibit and prevent its
retail clients from purchasing “ad words” on Google and other search search
engines, but didn’t.
The court applied Rule 9(b) to all the counterclaims as
grounded in fraud.
Telebrands argued that My Pillow’s Lanham Act claim failed
because it was based entirely on statements appearing on the websites of
third-party retailers. My Pillow argued that Telebrands is subject to
contributory liability.  The court
disagreed.  Under Lexmark, My Pillow had to plead and prove “economic or reputational
injury flowing directly from the deception wrought by [Telebrands’]
advertising.” [That alteration is doing a lot of work used to defeat a
contributory liability theory.]
Duty Free Americas, Inc. v. Estee Lauder Companies, Inc.,
797 F.3d 1248 (11th Cir. 2015), held that a plaintiff could assert a claim for
contributory false advertising, analogizing to contributory trademark
infrignement. Under that standard, the “plaintiff must show that a third party
in fact directly engaged in false advertising that injured the plaintiff” and
that the “defendant contributed to that conduct either by knowingly inducing or
causing the conduct, or by materially participating in it.”

But the Seventh Circuit hasn’t recognized contributory false advertising. “[S]uch
a claim would be inconsistent with Lexmark’s proximate cause formulation.”  [No it wouldn’t!  It would just identify the primary false
advertiser.  Lexmark didn’t address secondary liability.] Anyway, the court
rejected the claim even assuming the DFA standard
applied, because My Pillow didn’t allege that Telebrands engaged in the alleged
false advertising by inducing, causing, or materially participating in the
conduct.
[Courts recognize
contributory trademark infringement all the time; the relevant statutory
language supporting this type of liability, or lack thereof, is the same.  Say it’s not sufficiently pled, that’s fine,
but it’s no surprise that the court doesn’t give any reason that trademark and false advertising ought to be treated
differently.]
Because the IUDTPA, ICFA, and unfair competition claims were
the same as the Lanham Act, they also failed. 
[I often wonder why people don’t make more out of statutory
differences.  While what constitutes
deceptive advertising might and probably should be consistent across the
statutes, they often don’t have the same language for things like primary v.
secondary liability.  The precedents
linking Lanham Act and state law claims are about the core issue of
falsity/materiality/damage.]
Finally, My Pillow did meet the Rule 9(b) particularity
requirements for fraud with regards to indemnification for/policing of false
advertisements based on the CEO’s meeting with a specific Telebrands rep, but
failed to allege sufficient details regarding AdWords, including which words
should be covered, the content of ads, the identity of the relevant retail
clients, or when or where the allegedly violative ads appeared.
Breach of contract failed; it was just a reassertion of the
failed alleged violations of the Lanham Act, the IUDTPA, and the ICFA as a
breach of the compliance-with-law clause of the contract. The only other
specific statute that My Pillow identified was the FTC Act, but it didn’t
allege any specifics that support that claim.

from Blogger http://bit.ly/2DVoBB0

Posted in Uncategorized | Tagged , | Leave a comment

Legal Applications of Marketing Theory, part 5 (me on puffery)

Rebecca Tushnet, Harvard Law School, On Puffery
Puffery is a concept that purports to be about things
consumers ignore and don’t rely on. It is in fact a concept about things courts
ignore and won’t rule on.  At the moment,
marketing and other empirical work has essentially nothing to say about puffery
in the courts; puffery consists of precisely the elements of advertising for
which courts neither require nor allow empirical evidence of consumer
reaction.   That doesn’t make the
doctrine wrong, but it does mean that explanations for the doctrine should not
be founded in unsupported, mostly unsupportable judicial claims about how
consumers think and what claims they disregard. 
Instead, puffery should be about what kinds of claims are too difficult
to evaluate for their truth in judicial settings.  That’s an epistemological determination that
judges are actually well qualified to make.
Let me back up a bit: In modern advertising law in general,
only factual misstatements are actionable. 
Puffery is an overlay onto the fact/opinion divide: it allows courts to
reject liability for what might look like factual, verifiable claims (such as
the cheapest prices in the universe, or even the cheapest prices in West
Virginia ) because they are too exaggerated or vague to be believed by
reasonable consumers.  The Fifth Circuit
wrote, for example, that “non-actionable ‘puffery’ comes in at least two
possible forms: (1) an exaggerated, blustering, and boasting statement upon
which no reasonable buyer would be justified in relying; or (2) a general claim
of superiority over comparable products that is so vague that it can be
understood as nothing more than a mere expression of opinion.”  The FTC has reasoned similarly. 
Courts think, without evidence, that consumers don’t rely on
puffery.   This conclusion is also
normative, and it has distributional consequences—it is about how consumers
should behave, not about what advertisers should say. As Learned Hand wrote,
“There are some kinds of talk which no sensible man takes seriously, and if he
does he suffers from his own credulity.” 
The influential treatise Prosser & Keeton on the Law of Torts says
that an advertiser has a privilege “to lie his head off, so long as he says
nothing specific.” 
Ivan Preston argues that current puffery doctrine is a
mistaken evolution from nineteenth-century cases involving individual buyers
and sellers that held that buyers couldn’t sue for fraud based on statements
that they could easily have verified or disproved themselves.  When buyers were unable to verify the claims,
however, the law provided them redress. But as the puffery doctrine developed,
he argued, it turned into a rule that consumers treated certain claims as
meaningless and therefore rejected them at the outset.  He argues that this new rule was not only
unconnected to its historical foundation in fraud law, but also was
inappropriate for modern mass advertising where the complexity of factual
claims combined with their sheer volume mean that consumers can’t actually
investigate most of the factual claims they receive.
One Additional piece that has to be understood before the
full scope of the problem is understandable: advertising law, like trademark
law, is probabalistic.  If 25% of
consumers (net of control) are confused or deceived, almost any court would
grant relief.  Deception, that is,
doesn’t need to be universal to be actionable by a competitor, or by the
FTC.  Deception doesn’t even need to be
the most likely outcome for a given target consumer as long as a substantial
number of consumers are likely to be deceived. 
Resulting problems in the law of puffery: First, it is a
problem for the conventional justification of the doctrine that puffery
actually works, in the sense of getting consumers to buy things.  Even the FTC has accepted that puffery works:
C&H Sugar was ordered in 1977 not to call its brand “superior” to or
otherwise different from other granulated sugars without substantiation.  In 1995, it successfully argued that it
shouldn’t be barred from using ads such as “I love C&H the best” or
“C&H tastes best,” which harmed it because its competition was free to make
similar unsubstantiated claims. The FTC granted the modification, because
competing ad campaigns were able to “take advantage of C&H’s inability to
counter claims that … constitute puffery. . . .”  But, of course, if C&H needed puffery to
compete, then puffery was affecting consumer behavior.
If puffery didn’t work, we should probably expect it to be
rare.  Courts occasionally make the point
that advertisers both want to affect consumers and are likely have greater-than-average
insight into what might affect consumers in the sale of their particular
thing.  It seems like the setup to a
joke: why do claims appear in ads?  The
obvious answer seems to be: to get to the sale. 
One thing we might do when advertising claims are challenged in court,
then, would be to presume that a factual claim matters to consumers.  The key questions we should have would be
about whether a significant group of consumers receives a factual message
specific enough to be falsified.  [We could
still recognize that there are parts of ads that aren’t claims as such—for
example, elements of ads that functioned to attract attention, thence to
deliver a factual claim.]  I would
suggest that the concept of unbelievability adds nothing further to the
question of falsifiability—it’s possible that a sufficient exaggeration means
that no falsifiable factual message has been conveyed, but we really don’t know
that at the wholesale level, without looking at the specific exaggeration and
the market.
I want to work through two examples from the FTC to show
what I mean when I suggest that the current conception of puffery as meaning
something about actual consumer perception is not working very well.
First, the FTC Endorsement Guides.  If you think that puffery is about
subjectivity and variation among consumers’ understanding and that reasonable
consumers don’t rely on puffery, the FTC’s approach to endorsements shouldn’t
make sense to you. The FTC takes the position that an endorser has to disclose
connections to an advertiser when they wouldn’t be obvious from context and
when knowledge of the connection would be relevant to the consumer in weighing
the endorsement.  So far, so good. But
the FTC—quite rightly, I think—requires disclosure even when the endorser is
otherwise just offering her opinion: these clothes are so cool! This hair color
looks fabulous on me! Failure to disclose the connection is deceptive where the
audience is likely to believe that the speech is uncompensated opinion.  If the underlying claim is pure immaterial
puffery of the kind on which consumers are irrebuttably presumed not to
rely—and the underlying claim in a social media endorsement is often indeed
exactly that kind of claim—how can it possibly be important to consumers to know
that the endorser is being compensated?
The answer is that consumers, in general, want opinions to
be in some sense authentic, and they care about whether a speaker is getting
paid; her influence will be less if she discloses that payment.  The fact of the financial connection is
itself verifiable, so its absence can be misleading, even if all that gets said
in an endorsement is stuff that consumers weren’t supposed to be relying on as
a matter of law. The endorsement guidelines thus inherently, if covertly,
recognize that puffery does work. 
Because puffery works, it is important to regulate undisclosed
endorsements, whether or not they make other factual claims.  The lack of disclosure gives us a factual
hook of sufficient specificity that the courts and the FTC can handle:
determining whether there was in fact an undisclosed relationship.
Second, the FTC Green Guides. In puffery discussions, courts
often say that vagueness matters: some words or statements are too vague to
have one specific meaning.  That was the
rationale, for example, in a case involving the claim “America’s Favorite
Pasta.”  There are different possible
meanings of vagueness: a statement might be too vague even for an individual to
get a specific message in response to the statement, but the statement might
also have a lot of varying interpretations among heterogeneous consumers, at
least some of which have specific definitions in mind. The AFP court endorsed
the latter view, saying that favorite might mean most-purchased, but it might
also mean that people liked it best but couldn’t often afford it.  Yet if the thought is that different
consumers will fill out words like “favorite” with different meanings, then we
could if we put the empirical work in actually figure out what those meanings
are and whether they’re shared across a substantial number of relevant cases.
Which brings me to the Green Guides: The FTC’s general rule
for advertisers is that they have to substantiate factual claims that are
conveyed to a substantial number of relevant consumers.  FTC, relying on its own research into the
meaning of general environmental benefit claims (“green” and “eco-friendly”),
found that substantial numbers of consumers understood a variety of things from
those claims:
61 %: made from recycled materials;
59 %: recyclable;
54 %: made with renewable materials;
53 %: biodegradable;
48 %: made with renewable energy;
45 %: non-toxic;
40 %: compostable
27 %: no negative environmental impact.
As a result, the FTC said in its Green Guides that
(b) Unqualified general environmental benefit claims …
likely convey that the product, package, or service has specific and
far-reaching environmental benefits and may convey that the item or service has
no negative environmental impact. Because it is highly unlikely that marketers
can substantiate all reasonable interpretations of these claims, marketers
should not make unqualified general environmental benefit claims…..
I think this is a correct treatment of vagueness that has
multiple plausible falsifiable meanings. If a substantial number of consumers
receives a sufficiently specific and false meaning, we should be concerned.
Thinking of puffery as being about consumer comprehension
instead of administrability leads courts into mistakes. Example: In Date v.
Sony Electronics Inc., 2009 WL 435289 (E.D. Mich. 2009), Sony advertised its
television as offering “Full HDTV,” and “1080p” (the best available
technology). The TVs, however, could not display a 1080p signal. Instead, at
best they could display an upconverted 1080i (interlaced) signal from a 1080p
device. The upconversion process results in undesirable artifacts like
feathering that make the viewing experience worse.
Sony argued that its claims were puffery, based on a prior
similar case. In Johnson v. Mitsubishi Digital Electronics America, Inc., 578
F. Supp. 2d 1229 (C.D. Cal. 2008), the court concluded that, although
Mitsubishi designated its television set as a 1080p television set, the phrase
1080p “does not convey a specific claim that is recognizable to the targeted
customer.” The Johnson court thought 1080p only had meaning for engineering
professionals, and that all that the plaintiff wanted was a top-of-the-line set
(top of the line is classic puffery). Because he didn’t understand what 1080p
meant, the claim was puffery to him.
The Date court pointed out that Sony put the term on its
specification sheet addressed to consumers, suggesting that it wasn’t puffery.
But more evident, I would argue, was that 1080p had a specific meaning, and
consumers didn’t need to know its technical requirements in order to be moved
to act by it any more than they need to know how their statins work or why the
drugs are called statins.  If a consumer
receives a message that she thinks is factual, credible and material, even if
she can’t be particularly specific about the details, then she can be harmed if
that message is false.  And it was really
easy to prove that 1080p was false as applied to the Sony TV.  But focusing on consumer understanding leads
to errors like the Mitsubishi court’s.
Some preliminary thoughts about implications: First, I want
to revisit the difficulty that puffery works: Puffery may be effective in
influencing purchases without being either provable or falsifiable in conventional
judicial terms. Thus, a determination that a claim is pure puffery should
arguably trump evidence that it actually influences consumers—but only if the
reason for finding puffery is the difficulty of proof of truth, rather than
vagueness or multiple possible meanings. And, as I suggested earlier,
exaggeration should be rejected as a separate defense or category of puffery;
the question is always what factual message consumers are likely to receive, if
any.  If the claim is “we’ll save you a
million dollars on car insurance,” we can ask whether a substantial number of
consumers receives a message that they can expect to save a significant amount
compared to other insurers, and whether that message is false.  The lawyers’ fighting would of course shift to
whether the inquiry into falsity was a manageable judicial task from current
disputes over puffery—but at least we’d have better definitions, and courts
forced to consider heterogeneous groups of consumers might even be moved to
look more rigorously for multiple possible meanings in an ad, where
appropriate.
What’s the proper boundary of falsifiability, then?  I think it should have to do with the
difficulty of getting reliable results from consumers, or of figuring out what
the possible specific factual meanings are.
This approach also has implications for judicial treatment
of images. The Second Circuit has said that 
Time Warner Cable, Inc. v. DirecTV, Inc., 497 F.3d 144 (2nd Cir. 2007):
“Unlike words, images cannot be vague or broad.” While one standard definition
of puffery—general claims of superiority that are so vague as to be
meaningless—fits images badly, the other—“an exaggerated, blustering, and
boasting statement upon which no reasonable buyer would be justified in
relying,” could be applied.  This to me
gets it absolutely backwards!  Not all
images have completely transparent meanings; especially in ads, images need to
be interpreted.  So images absolutely
could convey a vague or broad meaning, depending on what the ad was doing. But
the Second Circuit’s abandonment of verifiability and focus on reasonable
reliance led it to judge consumers—and to find them wanting.  In Time Warner Cable, Inc. v. DirecTV, Inc.,
497 F.3d 144 (2nd Cir. 2007), DirecTV ran Internet ads showing unwatchable TV
images contrasted to sharp and clear images. The district court agreed with
Time Warner that DirecTV’s own rationale for running the ads—that consumers
were highly confused about the then newly emerging HD technology and needed to
be educated that both digital equipment and digital signals were required to
experience HD quality—was reason to think that consumers might rely on the ads.
The court of appeals found that the district court clearly erred. The ads were
not even remotely realistic, and the court found it difficult to imagine that
any consumer, no matter how unsophisticated, could be fooled into thinking
cable’s picture quality would be that bad. 
I would suggest that’s a problem of the court’s imagination; a consumer
might know that “ordinarily” her cable wouldn’t be anything near that bad. But
why would a consumer transitioning to HDTV have been confident about what cable
would look like when she attached an analog cable feed to her new HDTV?
A final thought on the role of cost-benefit analysis: One reason
we might reject liability even if a significant number of consumers receives a
false factual message from a claim is that the claim provides benefits to a
different group of consumers, significant in size or in some other way.  That’s not a justification that requires a
puffery defense, nor does a puffery defense obviously help explain what
benefits the nondeceived consumers might be getting—by definition, if the issue
is puffery then they’re not getting specific truthful information, though maybe
they’re getting enjoyment from a cool ad. 
A clearer understanding of puffery could help us when we ask “is there
anything lost to the nondeceived group if we get rid of or reformulate the part
of the message that’s causing the deception?”
Q: more discussion of online reviews by individuals. Their
ability to puff all they want if unaffiliated may be some of their
attraction.  Also compare to gov’t:
cities can puff all they want about how they’re great places to live. If we
regulate puffery in advertising, won’t people be vulnerable to deception by
uncaught puffers?
RT: I don’t think there’s any evidence that the general
advertising regime can teach consumers an appropriate level of
skepticism—credulity seems to vary by demographics.  I want people at least not to be fooled when
they buy TVs.
Q: cheap talk/costly talk in economics: at what point is
information ignorable?
Q: remedies: research suggests you can’t combat puffery
w/facts, only w/anti-puffery: “best pen on earth” has to be fought with “worst
pen on earth.”
RT: similar to Green Guides, where even adding explanation
“green: made with recycled materials” conveys a bunch of other green claims.
Q: endorsement: isn’t the problem that the person who’s
selling is anticipated to puff, but if someone else is puffing, it’s
interpreted as their unbiased opinion to which people can pay attention?
RT: but that still means that there’s actionable information
in the semantic content of the words—to say consumers don’t rely on puffery is
just wrong.  It’s true that the deceptive
part is the failure to disclose, but it then affects whether the puffery is
“credible.”

from Blogger http://bit.ly/2WngMuW

Posted in Uncategorized | Tagged , , , | Leave a comment

Legal Applications of Marketing Theory, part 4

Legal Applications of Marketing Theory, part 4
Steve Ansolbahahere & Jacob Gersen, Harvard University,
Dept of Government & Harvard Law School, Consumer Confusion in the Law of
Food (Are People Misled?)
Pom Wonderful case: Pom Wonderful Pomegranate Blueberry 100%
juice; 85% pomegranate juice and 15% juice from concentrate.  Minute Maid made a Pomegranate Blueberry
blend of 5 juices with almost no pomegranate juice.  Kathleen Sullivan for Coca Cola said that
consumers weren’t so unintelligent not to recognize the blend; Kennedy says “I thought that this was pomegranate
juice.” 
So what are people thinking, and in particular what do they
want (what are their most material preferences)?  Nelson’s theory of search, experience, and credence
claims.
Survey about which drink would be sweeter: POM 19%, Minute
Maid 43%  [remainder: no difference]
Tastes better: 30% versus 28%
Costs more: 51% versus 15%
Is organic: 29% versus 7%
Is a Pomegranate drink: 54% POM, 10% minute maid
Regression: which would you buy?  Real pomegranate juice matters; taste is
important; nutrition is important
Survey about role of price versus health versus taste.  Labels affect perceptions of various
attributes; filtered through value or weight that people place on each
attribute. Health and nutrition are usually what people care about most, so
inferences about those things have very large effects.
Health claims about foods are tightly regulated; consumers
are trying to get information that they can’t get from the info so they are
making lots of cross-attribute inferences.
Halo/horn effects: inferences across all dimensions at once
come from the label GMO: people assume that it’s as bad as trans fat, as bad as
high calorie.
Q: Pom established perception of health w/juice.  Effect could be coming from the color of the
juice, even from Minute Maid.  It
wouldn’t be linear.
A: probably true.
Q: consumer preference not to be fooled?
A: there probably is—Scroogled campaign was effective in
accusing Google of malfeasance.
Q: represented Ocean Spray in similar case. It wasn’t just
the color; the labels had pomegranates all over them and not the juices that
made up the bulk of the product. 
Pomegranate was a hot ingredient! But the health point is important. The
attributes aren’t just correlated but in some sense the same; healthy is highly
regulated so sellers have found lots of other ways to say it. Any claim about
presence/absence of any nutrient is interpreted by consumers as a general
health claim.  So are you just getting at
“health”?
A: there were pomegranates on both products’ labels, but
health/nutrition perceptions differed between Pom and Minute Maid.
Q: but it tracked the health conclusions.
A: mindful of what is activating those impressions—it’s not
consistent or easy.
Q: preference for truth speaks to a remedy, not necessarily
a consumer preference. If I’m misled about something not material to my choice,
maybe I don’t deserve $, but the labeler should still possibly be punished for
lying.  Distinction b/t info given to
consumer/respondent and actual label—when I rely on a label for health related
information, I actively search for it. Color isn’t something I actively search
for—I receive it passively. 
A: we varied things like calorie content, sugar, in our
tests.
Q: but drawing their attention to it may make a difference.
A: he’s skeptical that people don’t look at labels.  A lot of people do, not every single time,
but at least at purchase initiation.  If
there was no benefit to saying it, the company wouldn’t spend money to say it.
They think it matters.
RT: I would have some Qs about the role of the TM versus the
specific juice, including what they think “pomegranate drink” means.  It could be just a brand effect/people
thinking “pomegranate” means Pom Wonderful. 
If that’s true then the regulatory challenge is even greater.
A: Doesn’t seem to happen with Wesson v. Mazola oil, or Muir
Glen v. Swanson canned tomatoes.  [Which
might be perfectly consistent w/a brand effect to the extent that Minute Maid
and Pom are known for particular slices of the juice market, whereas those
brands don’t have distinctive health/nutrition profiles in their categories.]
Discussion re: harm to consumer v. harm to competitor being
different things.
David Hosp & Mark Puzella, Orrick & Orrick, Profit
Disgorgement in Trademark Litigation
Needs to be tied to the relevance of causation.  Came out of work for Wal-Mart on Wal-Mart’s
litigation over Backyard for grills (v. Backyard Barbecue for another store).  Found to have been willful infringement.  Now it’s a disgorgement case: but whatever
Wal-Mart sells, it sells $1 billion—over $1 billion of grills/grilling
accessories. The Lanham Act allows profit disgorgement. How do you fight out a
damages battle where the damages might even be trebled [but it couldn’t go over
$1 billion—it has to be compensatory and not a penalty, not like antitrust].
The judge was thinking $500 million.  We
tried it and got it down to about $35 million. 
Reversed on appeal; tried to jury and got $90 million verdict, now on
appeal.  Comes down to the Q of damages
definition.  Lanham Act doesn’t define
infringer’s profits; case law is over the map. 
Damages have to be attributable to the infringement.  P’s burden: show revenues. D’s burden: show
what shouldn’t be counted, including costs of goods sold.  If you start with $1 billion, that might get
you down to $450 million—now what?
Figure out what’s attributable to the brand.  If you’re looking for a $25 grill, nobody
cares it’s called Backyard.  Different
possible surveys, regression analysis. 
Juries understand hard numbers. 
Ultimately, P’s burden of showing revenues, but attributability gives D
a chance to attack causation. The burden is on D to show lack of causation, but
that still ought to be open as an avenue for the D to show it’s not tied to the
infringement.
When he was starting out, people didn’t think TM cases
involved damage awards. That’s changing, particularly as patent law is being
curtailed in its competitive uses. 
Companies are shifting to trade dress claims.  Mahindra: offroad vehicle they’ve been making
for 70 years, initially under license from the Jeep corp. Sued by Fiat/Chrysler
for trade dress infringement. Causation will get a lot of attention under the
next few years.
Q: Going to defend the jury. 
You use names in your presentation for authority—doesn’t that indicate
something about the value of names? 
Maybe that’s the role of the jury: to think about how they do their
shopping and whether it matters.
A: We want to figure out the appropriate structure for
showing that names matter.  [Or trade
dress.]  Our chapter seeks a
framework.  The jury needs instructions.
Q: Backyard v. something else. What’s the counterfactual?
Wal-Mart not selling grills, or using the name Frontyard, or Weber, or
something else?
A: Wal-Mart took Backyard off its products; used same
labels, color scheme, etc. except it had no name whatsoever.  “Grill” instead of “Backyard Grill.” No
impact on sales/sales went up slightly. 
We would view that as the counterfactual.
Q: would you advise your client next time to roll out
different styles in different places to establish the counterfactual?
A: we deal with that a lot. 
W/a large corporation, you have to assume that the profit margin on
white label is so much higher than national brands that companies are moving
more and more into white label. They like having a brand name; they want it to
be descriptive; inevitably someone has a registration for something that’s at
least borderline close. [See Barton Beebe & Jeanne Fromer’s empirical work
proving this.] That is a recipe for getting sued.
Q: why isn’t a company as big as Wal-Mart doing small
experiments to measure possible damages?
A: this is a newer issue; we’ll see more companies hit with
large verdicts.  There are also internal
pressures from marketing folks who fell in love with a name and got it
cleared.  Legal knows it can’t be the
department that always says no.
Q: (1) what survey form/controls did you end up using that
are public? (2) hypothesis: causation is important and underthought at this
stage b/c modern TM lacks a materiality requirement in the first place, which
it should have preserved from the old common law. (3) Also, be interested to
have you speak to relationship b/t irreparable harm and difficulty calculating
damages—does showing that it’s really hard to trace damages support the
pre-eBay practice of having injunctive relief be standard?
A: survey asked people their motivations for purchase. Need
more work on surveys about causal relationships with sales—may see more of
those in survey world.
Q: survey world can definitely produce! Why did Wal-Mart
choose a name if it can sell grills w/o?
A: consumers expect to see a name. Marketers want something
that actually fits w/the product category, doesn’t turn the consumer off.
Doesn’t have to drive sales, just make sense to the consumer.  Interesting Q whether it is actually
necessary.
Q: causality argument on disgorgement makes it a mirror
image of a lost profits claim. If the P can seek either form of remedy, is
there a concern that by pushing causality into disgorgement we’re taking away
one of the remedies the legislator thought was important?
A: depends on the case. 
Maybe there is a name that really does drive sales.  Reverse confusion case.  Damages and profits are related, for sure.
They should relate to one another.
Q: how much is a conceptual challenge v. challenge of
proof?  Conceptually it’s clear that the
damages are either lost profits or disgorgement of d’s profits.
A: there is a conceptual challenge b/c the language of the
Lanham Act allows for both [if not duplicative].  There were instructions on both and awards for
both in our case.  Notion of causation is
not very well explored in the case law.
August Horvath, Foley Hoag, Damages Estimation in Consumer
Deception Class Actions:  Legal and Methodological Issues
Chapter is about consumer class action damages: there’s a
lot of blame to be spread around on judges, litigators, expert witnesses,
system of litigation structure.  It’s
unrealistic to say there’s no such thing as a model that can estimate classwide
damages—judges will reject it because it will remove the remedy [I’m not so
sure about that]. 
In most jurisdictions, the only way to show damage is to
show price premium; the other possible ways to show harm don’t work in American
courts.  What happened hypothetically in
a world without the false claim? 
Consider: powdered infant formula with powerful brand + false claim
about preventing allergies.  Creates a
new demand curve compared to the equilibrium pre-false statement.  Doesn’t affect the supply curve at all, since
falsity is costless (unlike incorporating a patented feature into a product).
Conventionally there should be a volume increase and a price increase.  Companies don’t really know their own demand
curve (or supply curve), though, which complicates things.  Executive may choose b/t trying price
increase and looking for volume increase. 
In theory, false advertising damages to consumers are from just that
change in price and supply.
But conventional damages models for class actions look at
WTP, at consumers rather than at the consumer/producer interface. The basic
Lanham Act damages measure is profits/damages diverted.  Does conjoint analysis get us to the actual
surplus affected by shifting the demand curve? No, it doesn’t.  No conjoint analyst has ever convinced him
that it explains the interaction between supply and demand, or whether the
price produced by conjoint analysis lives anywhere on a supply/demand
curve.  In principle, a part worth is
individual to each consumer—some value an attribute negatively, positively, not
at all.  But experts assume there is a
part worth for each attribute representing WTP. 
If the distribution is normal instead of uniform, then it’s not clear the
result is the same.  If the center is the
mean, then raising the price by that amount would seem to lose half the
consumers (the attribute wouldn’t be worth paying that much for the half below
the mean), so seller won’t do it. 
The supply curve is also relevant.  Some experts then assume that they’d raise
prices so that the supply would be the same and the price would be higher. But
that’s a completely unrealistic assumption about pricing. Courts have accepted
it b/c they’re desperate.  Supply side:
the words courts use to explain constraints on manufacturer other than
demand—but it’s not quite the right words because of the presence of
retailers/middlemen.  Wal-Mart has price
requirements; the formula maker had no ability to raise prices at will.  At most it can take the increased sales at
the same price.  Need more sophistication
but at the same time learn the sloganeering that helps explain them to courts
to avoid the bad analyses that courts have accepted in the past few years.
Q: vast majority of conjoint analysis he’s seen in
litigation are crap b/c experts who produce them don’t understand it.  There are perhaps a dozen people who could do
that right; his guess is that Horvath hasn’t seen those.  The supply/demand curves presented reflect
monopolies, not competitive markets.  If
Minute Maid has a false advertising campaign changing the probability of
choice, competitors may or may not react; if you recognize a competitive
market, the best way to explain it is not by adhering to a curve like
that.  The best way to analyze it is a
market simulation with a variety of competitors. If you change an attribute in
conjoint analysis, you change a market share that is simulated by, say, 1000
respondents.  Need experts who understand
the power of the tool.
Q: Some of these could be argued as estimates of the maximum
possible change—the jury could see that simply.
Q: Conjoint is sensitive to so many small things; uniformity
in design is lacking, even before you run any simulation.
A: at the level of class certification, that’s not where we
need to focus—that’s for later in the analysis. 
That kind of objection will be dismissed by the court as weight v.
admissibility—the court just wants to know whether the model in principle can
do the job at this stage.

Michel Pham, Columbia Business School, A Consumer Psych
Perspective on Source Identification and Confusion
Consumer source identification—similar to identification of
painter of a painting.  How does it work?
Long-term memory & knowledge.  For
source identification to take place, consumer needs sufficient exposure to the
stimulus. Opportunity to process: sufficient sensory access to stimuli (size,
location, distance, movement, lighting conditions, loudness), pace (speed of
movement, rate of speech).
Attention is limited. 
Attention depends on level of involvement (greater in context of active
purchase decision, lower elsewhere as in post-sale confusion allegations).  Stimuli are more likely to attract attention,
all else equal, if they are large or intense, vivid in color, contrast
w/background, are centrally or prominently located. Not just driven by physical
characteristics; greater for familiar and recognizable stimuli.
Next, perception: the mental registration of sensory inputs
into a coherent, unitary whole. Perception is holistic and strongly oriented
towards organization and pattern matching, not compositional/feature by
feature. We group things that are proximate, we fill in missing info that seems
consistent. Subject to least noticeable variation.  Perception is subject to the principle of
just-noticeable differences. People can only perceive things that exceed a
certain threshold.  Adidas v. Payless:
three stripes v. four.  That may not be
bigger enough to be recorded.  Five
stripes may look different enough.
Perceptions of similarity of A & B are driven by degree
of overlap b/t features of A and features of B. Tversky’s theory of similarity.
Converse v. Skechers: why do the shoes look similar?  A lot of common features and few not common
features.

Categorization: labeling and identifying objects as belonging to a
group/category we already know. (Here
is an awesome post about categorizing a “dog.”
)  Fundamental to human functioning. Identifying
a product as belonging to a particular brand is a classic example of
categorization; brands function like categories in consumers’ minds.
Categorization is often spontaneous, “automatic.” Holistic and based on overall
configurations.  Consumers may not be
able to verbalize the basis of categorization-based source identifications.
Cues used in categorization have three characteristics: they’re observable, typical
of the category, and atypical of things that aren’t in the category.
For categorization to take place, the match to typical
category cues doesn’t have to be perfect. Everything else equal, stimuli are
more likely to be categorized in categories that are highly
accessible/well-known brands: a glass of soda will be shorthanded as a “Coke.”
Comprehension: interpreting a stimulus to extract
higher-order meaning from it. Inferences based on existing knoweldge. Two
common rules: representativeness: attribute to brands that are perceived to be
most representative of, or semantically related to the stimulus. Prominence:
attribute to brands perceived to be large and prominent in the marketplace. So
if I show you a soccer/football championship and ask who’s the sponsor, people
will say Gatorade; if I show a chess championship, they guess Microsoft is the
sponsor.  Ongoing case: RBX and Reebok
shoes—does one suggest the other?
Q: seems to resemble machine learning w/images. Anything to
be learned?
Q: dual processing theory? System 1/system 2?
A: don’t like that theory; not a good division. But a little
alignment: front end looks a bit like system 1, back end more like system 2.
Q: common for products to have lots of attributes, but
consumers are limited in perceiving them.
A: the number of cues you use isn’t not necessarily taxing
mentally if you’re pattern matching. 
More of an issue: if you have competing cues.
RT: (1) Role of preference for or against cognition? [He
thinks it doesn’t mean that they categorize differently in a first pass.] (2) Special
problems of trade dress: need some extra principles to figure out what should
happen when some of the similarity is due to functional features. [You can
control for role of the functional features by changing them in controls.] But
that’s not the end of the question: one could have a rule that confusion caused
by similarity in unprotectable features must be ignored, or one could have a
rule that the defendant is required to stay further away in other ways—add
differentiating extras—if it uses those unprotectable features.  [He agrees that part is for lawyers to fight
about.]
(3) Sponsorship research on attribution of sponsorship to
prominent brands, e.g. Samsung will be more easily perceived as a sponsor of
the Olympics just b/c it’s prominent. 
But doesn’t that mean that sponsorship, association, affiliation and
approval based on similarity as
opposed to based on prominence will be difficult or impossible to detect? Is
this about what kinds of controls we should be using in sponsorship cases?
Bert Huang, Columbia Law School, Marketing Ethics Through
Law
Effects of law on trolley problem: what if we tell subjects
(1) criminal law prohibits turning trolley, (2) there’s criminal law, but not
enforced, (3) law considers it justified, (4) duty to turn trolley, but not
enforced, (5) legal duty to turn trolley. 
Can knowing law influence moral intuitions?  People who learn it’s criminal tend not to
say it’s morally required to turn the trolley; if it’s required, they tend to
say it is.  Asked if it’s morally
prohibited to turn, they are more likely to say yes if it’s legally
prohibited.s
Looking for: Ethical questions where ethics can go both
ways, and law can believably go both ways, and scenario is easily imagined.
For example: search engine paid results. Google Assistant
gives oral results; should it have to label ads? Is it ethical?  Ask them what if the law said there’s a need
to disclose ads versus it’s fine b/c of the First Amendment.  Or Free app sells your data to marketers,
discloses but knows nobody reads the fine print.  What if the law said that wasn’t a real
choice v. the law said it’s fine.
Dietary supplements: claims are based on junk science but
there are no negative studies showing harm. What if the law said: first, need
good science v. claim is fine until harm is proven. [I’d be interested in
checking doctor v. marketer as the speaker for this.]
Q: California’s Made in the USA high standard—95% of value
has to be made/sourced in the US. New Balance makes shoes that don’t meet that
standard: 70% of the value comes from the US. 
Expressed in its marketing.  There
was a settlement.  New Balance is the
only major manufacturer w/manufacturing in the US.
Q: Slack fill: ask if it’s ok. Product packaging: Barbara
Kahn’s work on the shape of the package influencing perception of amount.
RT: Wal-Mart’s Equate headache remedy comes in a red box
marked migraine and a green box marked headache; the green is much cheaper. The
ingredients are the same.  Is that
ethical?  Also: Ask them about parol
evidence/salesperson who lies!
Q: ask advertisers too what they think is ethical, not just
consumers.
Q: why this question? What is the ultimate goal?
A: knowledge.
Q: ethics of pricing: AZT for AIDS when it first came out.
Q: difference b/t political speech and advertising: why is
lying ok in #1 and not #2?
Q: do people favor monopolists v. competitive markets?

from Blogger http://bit.ly/2DRHx3E

Posted in Uncategorized | Tagged , , , , , , | Leave a comment